A possible relationship between thrombosis and oral contraceptives was first suspected in 1961, when fatal pulmonary embolism occurred in two young Californian women who had been receiving Enavid (7. Amer. med. Ass., 1963) . In England a case report (Jordan, 1961 ) and a leading article (Brit. med. 7., 1962) further directed attention to this association. Statistical evidence, however, has been regarded as failing to substantiate a causal relationship between oral contraceptive drugs and thrombotic disease (Chicago Conference, 1962; Mills, 1964) .
Laboratory investigations into the possible changes in the coagulation balance which might significantly add to the risk of thrombosis have yielded conflicting results. Phillips et al. (1961) studied the effects of exogenous steroids on the clotting mechanism of human subjects. Their results indicate that 19-nor-steroid compounds produce a significant rise in profibrinolysin and fibrinolysin levels and a less marked increase in antifibrinolysin. Recently Egeberg and Owren (1963) reported that norethynodrel in recommended contraceptive dosage produced an increased coagulability of the blood as evidenced by shortened plasma cephalin time, greatly increased antihaemophilic A factor, and slight increase in proconvertin activity' In addition, an increase in fibrinogen concentration was noted by Brakman and Astrup (1964) . On the other hand, Sobrero et al. (1963) were unable to demonstrate any alteration in coagulation factors.
Although the pathogenetic relation between 19-nor-steroid compounds and thrombosis has not been clearly defined, increasing reports of thrombosis in patients receiving this medication are of grave concern (Gaylis and Kramer, 1962;  Lorentz, 1962 ; McIntyre et al., 1962; Richman, 1962; Staddon, 1962; McWilliam et al., 1963 ; Minogue et al., 1963; Reed and Coon, 1963; Cohen and Sajid, 1964; Schatz et al., 1964; StewartWallace, 1964; Zilkha, 1964; Baines, 1965; Hartveit, 1965; Leather, 1965) .
We therefore wish to record the case histories of three patients in whom intravascular thrombosis occurred while on oral contraceptive drugs. The patient had five children, the youngest of whom was 1J years old. Her pregnancies had been normal and were uncomplicated by toxaemia, haemorrhage, or thrombophlebitis. During the previous year she had been taking, for oral contraceptive purposes, Anovlar (norethisterone and ethinyloestradiol) on a cyclic regime of a 20-day course of one tablet daily, starting on the fifth day after the menstrual cycle.
Bhrm MEDICAL JOURNAL 1587 fallen to 9.9 g./100 ml. and the white-cell count was 7,900/c.mnn. Repeated sputum cultures were negative for pathogens. Serum lactic dehydrogenase was on consecutive days 397 and 425 units (normal upper limit for this laboratory is 380 Steinberg units). An electrocardiogram showed a small primary R wave in leads VI and T-wave inversion Vi and V2.
It was decided to start the patient on anticoagulant therapy on the assumption that the chest lesions might represent pulmonary embolic disease, and heparin 10,000 units subcutaneously was given sixhourly. From this point onwards she began to improve slowly. On 21 June, 10 days after development of the lesions on the right side of the chest, she complained of pain in the calf and behind the knee in the left leg. On examination there was a half-inch (1.3-cm.) swelling of the mid-calf of the left leg with tenderness in the popliteal fossa; Homan's sign was positive. Heparin therapy was continued with the addition of oral warfarin sodium.
On 2 1000 F. (37.8°C.) . For the first three days of her illness she had few appreciable chest symptoms, but the third day a persistent cough had developed. Over the next few days she had pleural pain along the left lower ribs. The cough became associated with a tenacious red sputum, and at this stage she was confined to bed. Her family physician treated her with ampicillin, but as her condition failed to improve she was admitted to hospital on the tenth day of her illness.
On admission she appeared gravely ill, extremely dyspnoeic, and cyanosed. The temperature was 103°F. (39.4°C.), pulse rate 110/minute, and respiration rate 35/minute. Examination of the chest revealed dullness and diminished air entry at the left base. There was no localized tenderness in the thighs or the calves; Homan's sign was negative. The erythrocyte sedimentation rate was 30 mm./1 hour, haemoglobin 11.3 g./100 ml., and white-cell count 8,600/c.mm. Sputum was sent for culture and the patient was started on crystalline penicillin, one million units three-hourly. By the third day of this treatment her condition had improved slightly. She was less dyspnoeic, but the severe cough and haemoptysis continued. A chest x-ray examination showed consolidation in the left lower lobe with possibly fluid in the costophrenic angle. Her condition continued to show further improvement, but on several occasions a spike in her temperature occurred to 101 and 1020 F. (38.3 and 38.90 C.) .
By the seventh hospital day it was apparent she was deteriorating. Jugular venous pressure was elevated and the pulmonary second sound was accentuated. At the right base there was slight dullness with diminished air entry. A chest x-ray film showed slight resolution of the consolidation in the left lower lobe. The right lung field was regarded as clear. Twenty-four hours later a further chest x-ray film showed a small area of consolidation in the right lower lobe (Fig. 3) . Other findings at this stage were that the haemoglobin had of these towards the thoracic inlet (about 5 to 6in. ; 12.5 to 15 cm.).
Injection with 60 ml. of 65% Hypaque was made and 18 films at two-second intervals were taken. The films showed that the main pulmonary artery was large. The main left and right pulmonary arteries were normal. There was blockage of two mid-zone arteries on the right, with good peripheral circulation above the avascular area (Fig. 4) The patient had three children, aged 7, 5, and 3 years. One month prior to the present illness she had started on Enavid (northethynodrel and mestranol), taking one tablet a day for a cycle of 20 days. She had stopped her first course of Enavid two days before the first symptoms.
Discssion
The possible association of thromboembolic disease with oral contraceptives has to be considered seriously in the light of the increasing number of case reports. Doubts that such a relationship exists are based on the concepts that pulmonary embolic disease is increasing (Morrell et al., 1963) and that thrombophlebitis is common in women of reproductive age (Chicago Conference, 1962 (1963) was unwilling to regard this as a reliable criterion, as the morbidity of thrombophlebitis has many uncertainties, such as the variation in reporting, diagnostic acumen, geographic differences in occurrence, and other factors. The committee considered that mortality data might provide more dependable evidence. However, they did not find any significant difference between thromboembolic deaths in Enavid users and in the general population (12.1 deaths per million and 7.9 deaths per million respectively), but possible hazards were observed in women in the over-35 age group (18.3 deaths per million in Enavid users as compared with 7.9 deaths per million in the general population).
We have felt it justifiable to report these three cases as they had the common manifestation of intravascular thrombosis occurring in young healthy women while receiving oral contraceptive therapy. A review of the literature discloses that most case reports have been concerned with the development of thrombophlebitis and pulmonary embolism. However, there has been occasional reference to spontaneous arterial thrombosis in young women on oral contraceptive therapy (Brit. med. 7., 1962; Reed and Coon, 1963; Schatz et al., 1964; Hartveit, 1965) . Recently attention has been drawn to the possibility that cerebrovascular disorders in young women may be related to this form of therapy (Stewart-Wallace, 1964 ; Zilkha, 1964; Baines, 1965) .
Case 1 would appear to be an adequately documented occurrence of thrombosis of the internal carotid artery in a healthy woman while on Anovlar. Clinical investigation disclosed some alteration in the lipid constitution ; while the cholesterol was normal there was an elevation in the total fatty acids. Necropsy examination did not show any atheromatous disease in the carotid arterial wall. At necropsy there was no evidence of local or systemic diseases associated with thrombosis.
It is, of course, true that young people may develop carotid artery thrombosis. In the accumulated literature Humphrey and Newton (1960) (Lemmen et al., 1958 ; Hutchinson and Yates, 1960; Humphrey and Newton, 1960 Reed and Coon (1963) . In the case reported by Cohen and Sajid (1964) death was due to massive pulmonary thromboembolism. Hartveit (1965) has described the case of a 32-year-old woman who died with coronary thrombosis while on Anovlar.
Summary
Three healthy women developed intravascular thrombosis while receiving oral contraceptive therapy. Case 1 was fatal and directs attention to the possibility that arterial thrombosis may also exist in addition to the more common thrombophlebitis of the legs and pulmonary embolism.
During the past four years 96 patients have been treated at this hospital with permanent pacemakers (Harris et al., 1965) . They have needed careful supervision to ensure continuation of satisfactory pacing, and to study and deal with complications.
The technical problems entailed (Davies and Sowton, 1964) have resulted in the setting up of a special weekly follow-up clinic, to which most of these patients return at regular intervals. For many patients artificial pacing has been lifesaving and has enabled them to return to a normal existence, but it can be maintained only by specialized aftercare techniques (Davies and Sowton, 1964; Sowton and Davies, 1964) 
